Drug Shortage Report for ATACAND
Report ID | 113490 |
Drug Identification Number | 02239091 |
Brand name | ATACAND TAB 8MG |
Common or Proper name | candesartan cilexetil |
Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH |
Market Status | MARKETED |
Active Ingredient(s) | CANDESARTAN CILEXETIL |
Strength(s) | 8MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 tablets |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2020-05-01 |
Actual start date | 2020-05-01 |
Estimated end date | 2020-05-20 |
Actual end date | 2020-05-13 |
Shortage status | Resolved |
Updated date | 2020-05-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | ZIEGELHOF 24 GREIFSWALD, MECKLENBURG - WEST POMERANIA GERMANY 17489 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2020-05-14 | French | Compare |
v6 | 2020-05-14 | English | Compare |
v5 | 2020-05-02 | English | Compare |
v4 | 2020-05-01 | French | Compare |
v3 | 2020-05-01 | English | Compare |
v2 | 2020-04-29 | French | Compare |
v1 | 2020-04-29 | English | Compare |
Showing 1 to 7 of 7